Literature DB >> 3196704

Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.

J W Fenton1, T A Olson, M P Zabinski, G D Wilner.   

Abstract

Activation of prothrombin to alpha-thrombin generates not only the catalytic site and associated regions but also an independent site (an exosite) which binds anionic substances, such as Amberlite CG-50 resin [cross-linked poly(methylacrylic acid)]. Like human alpha-thrombin with high fibrinogen clotting activity (peak elution at I = 0.40 +/- 0.01 M, pH 7.4, approximately 23 degrees C), catalytically inactivated forms (e.g., i-Pr2P-alpha- and D-Phe-Pro-Arg-CH2-alpha-thrombins) were eluted with only slightly lower salt concentrations (I = 0.36-0.39 M), while gamma-thrombin with very low clotting activity was eluted with much lower concentrations (I = 0.29 M) and the hirudin complex of alpha-thrombin was not retained by the resin. In a similar manner, hirudin complexes of alpha-, i-Pr2P-alpha-, and gamma-thrombin were not retained by nonpolymerized fibrin-agarose resin. Moreover, the ionic strengths for the elution from the CG-50 resin of seven thrombin forms were directly correlated with those from the fibrin resin (y = 0.15 + 0.96x, r = 0.95). In other experiments, the 17 through 27 synthetic peptide of the human fibrinogen A alpha chain was not an inhibitor of alpha-thrombin, while the NH2-terminal disulfide knot (NDSK) fragment was a simple competitive inhibitor of alpha-thrombin with a Ki approximately 3 microM (0.15 M NaCl, pH 7.3, approximately 23 degrees C). These data suggest that alpha-thrombin recognizes fibrin(ogen) by a negatively charged surface, noncontiguous with the A alpha cleavage site but found within the NDSK fragment. Such interaction involving an anion-binding exosite may explain the exceptional specificity of alpha-thrombin for the A alpha cleavage in fibrinogen and alpha-thrombin incorporation into fibrin clots.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196704     DOI: 10.1021/bi00418a066

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Hirulog-1 and -B2 thrombin specificity.

Authors:  J I Witting; P Bourdon; J M Maraganore; J W Fenton
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.

Authors:  C A Goodwin; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Crystal structure of the complex between thrombin and the central "E" region of fibrin.

Authors:  Igor Pechik; Joel Madrazo; Michael W Mosesson; Irene Hernandez; Gary L Gilliland; Leonid Medved
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

4.  Endothelin-like pulmonary vasoconstrictor peptide release by alpha-thrombin.

Authors:  D G Moon; M J Horgan; T T Andersen; S R Krystek; J W Fenton; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.

Authors:  F A Ofosu; J W Fenton; J Maraganore; M A Blajchman; X Yang; L Smith; N Anvari; M R Buchanan; J Hirsh
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

6.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

7.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.

Authors:  Igor Pechik; Sergiy Yakovlev; Michael W Mosesson; Gary L Gilliland; Leonid Medved
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

8.  Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Authors:  Joyce N Gonzales; Kyung-mi Kim; Marina A Zemskova; Ruslan Rafikov; Brenten Heeke; Matthew N Varn; Stephen Black; Thomas P Kennedy; Alexander D Verin; Evgeny A Zemskov
Journal:  Vascul Pharmacol       Date:  2014-01-25       Impact factor: 5.773

9.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Molecular mapping of the heparin-binding exosite of thrombin.

Authors:  J P Sheehan; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.